Literature DB >> 29866877

Pharmacodynamic and Immunomodulatory Effects of Micafungin on Host Responses against Biofilms of Candida parapsilosis in Comparison to Those of Candida albicans.

Maria Simitsopoulou1, Katerina Chlichlia2, Daniela Kyrpitzi1, Thomas J Walsh3,4,5, Emmanuel Roilides6.   

Abstract

Micafungin (MFG) demonstrates potent activity against biofilms of Candida albicans and Candida parapsilosis, the most frequent opportunistic fungal pathogens. Little is known about its immunopharmacologic effect on antibiofilm activity of phagocytic cells following exposure to Candida biofilms. In this study, we investigated the effects of MFG on human neutrophil-mediated damage of C. albicans and C. parapsilosis biofilms by XTT [2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] and the potential mechanisms underlying the immunomodulatory MFG activities on cultured monocyte-derived THP-1 cells in response to these biofilms by reverse transcription-PCR and sandwich and multiplex enzyme-linked immunosorbent assay. Preexposure of C. albicans to subinhibitory MFG concentrations significantly enhanced neutrophil-mediated biofilm damage, an effect that appears to be species specific since a comparable effect was not observed with drug-pretreated C. parapsilosis biofilms. Human THP-1 cells responded to both Candida biofilms through Toll-like receptor 2 (TLR2) and TLR4 upregulation, modest TLR6 involvement, and enhanced NLRP3 activation, whereas the signal was relayed to the nucleus via NF-κB p65 activation. MFG caused 2- to 3-fold lower TLR2 and TLR4 mRNA levels than those caused by either organism. C. albicans biofilms induced a robust proinflammatory response, whereas C. parapsilosis biofilms either alone or in the presence of MFG caused increased interleukin-1β (IL-1β) production, but small amounts of IL-8, IL-23, and tumor necrosis factor alpha. In conclusion, MFG may condition THP-1 cells toward an inflammatory response through TLR2/TLR4 recruitment. Inflammatory signals observed with C. albicans biofilms are considerably reduced upon exposure of THP-1 cells to C. parapsilosis biofilms, possibly enhancing fungal survival and increasing biofilm pathogenicity.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Candida biofilms; antibiofilm activity; immunomodulation; micafungin

Mesh:

Substances:

Year:  2018        PMID: 29866877      PMCID: PMC6105855          DOI: 10.1128/AAC.00478-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Proteomic characterization of human proinflammatory M1 and anti-inflammatory M2 macrophages and their response to Candida albicans.

Authors:  Jose Antonio Reales-Calderón; Noemí Aguilera-Montilla; Ángel Luis Corbí; Gloria Molero; Concha Gil
Journal:  Proteomics       Date:  2014-05-22       Impact factor: 3.984

2.  In vivo pathogenicity of eight medically relevant Candida species in an animal model.

Authors:  M Arendrup; T Horn; N Frimodt-Møller
Journal:  Infection       Date:  2002-10       Impact factor: 3.553

3.  Glucan-associated protein modulations and ultrastructural changes of the cell wall in Candida albicans treated with micafungin, a water-soluble, lipopeptide antimycotic.

Authors:  L Angiolella; B Maras; A R Stringaro; G Arancia; F Mondello; A Girolamo; A T Palamara; A Cassone
Journal:  J Chemother       Date:  2005-08       Impact factor: 1.714

Review 4.  Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

Authors:  V Krcmery; A J Barnes
Journal:  J Hosp Infect       Date:  2002-04       Impact factor: 3.926

Review 5.  Host defence against Candida albicans and the role of pattern-recognition receptors.

Authors:  Gerd G Gauglitz; Helene Callenberg; Günther Weindl; Hans C Korting
Journal:  Acta Derm Venereol       Date:  2012-05       Impact factor: 4.437

6.  Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.

Authors:  Maria Simitsopoulou; Pavla Peshkova; Efthymia Tasina; Aspasia Katragkou; Daniela Kyrpitzi; Aristea Velegraki; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2013-03-25       Impact factor: 5.191

Review 7.  Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis.

Authors:  Mohan Pammi; Linda Holland; Geraldine Butler; Attila Gacser; Joseph M Bliss
Journal:  Pediatr Infect Dis J       Date:  2013-05       Impact factor: 2.129

8.  Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model.

Authors:  Sona Kucharíková; Nidhi Sharma; Isabel Spriet; Johan Maertens; Patrick Van Dijck; Katrien Lagrou
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

9.  Specific pathways mediating inflammasome activation by Candida parapsilosis.

Authors:  Adél Tóth; Erik Zajta; Katalin Csonka; Csaba Vágvölgyi; Mihai G Netea; Attila Gácser
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

Review 10.  The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia.

Authors:  Emilio Bouza; Jesús Guinea; María Guembe
Journal:  Antibiotics (Basel)       Date:  2014-12-25
View more
  1 in total

Review 1.  How Biofilm Growth Affects Candida-Host Interactions.

Authors:  Emily F Eix; Jeniel E Nett
Journal:  Front Microbiol       Date:  2020-06-25       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.